Venu G Pillarisetty Selected Research

Therapeutics

1/2024	Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma.
10/2023	Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial.
1/2023	Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases.
1/2023	Leiomyosarcoma of the inferior vena cava: An uncommon malignancy requiring unique reconstructive approaches.
12/2022	KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
1/2021	Protocol for tissue slice cultures from human solid tumors to study therapeutic response.
1/2021	IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy.
10/2020	The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
7/2019	Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer.
1/2019	Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Venu G Pillarisetty Research Topics

Disease

37	Neoplasms (Cancer) 01/2024 - 09/2002
7	Adenocarcinoma 01/2024 - 01/2014
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 01/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2018
3	Melanoma (Melanoma, Malignant) 11/2022 - 06/2017
2	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 09/2017
2	Synovial Sarcoma (Synovioma) 01/2021 - 01/2019
2	Myxoid Liposarcoma 01/2021 - 01/2019
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 01/2014
1	Margins of Excision 01/2023
1	Pancreatic Fistula (Pancreatic Fistulas) 11/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Disease Progression 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Extra-Adrenal Paraganglioma (Paraganglioma, Extra Adrenal) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Inflammation (Inflammations) 01/2019
1	Liver Neoplasms (Liver Cancer) 07/2018
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Liposarcoma 09/2017
1	Hematologic Neoplasms (Hematological Malignancy) 06/2017
1	Bites and Stings (Sting) 06/2017
1	Leiomyosarcoma 11/2016
1	Leiomyoma (Uterine Fibroids) 11/2016
1	Neoplasms, Cystic, Mucinous, and Serous 03/2015
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 03/2015
1	Carcinoma (Carcinomatosis) 10/2014
1	Choledochal Cyst (Choledochal Cysts) 10/2014
1	Metaplasia 10/2014

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2014
5	Neoplasm Antigens (Tumor Antigens)IBA 11/2022 - 09/2002
5	AntigensIBA 01/2021 - 05/2006
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 09/2017
3	Interleukin-10 (Interleukin 10)IBA 08/2023 - 01/2023
3	Interleukin-12 (IL 12)IBA 08/2023 - 06/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2017
3	ChemokinesIBA 01/2022 - 10/2020
2	Interleukin-15 (Interleukin 15)IBA 08/2023 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 09/2017
2	InterferonsIBA 12/2020 - 01/2019
2	Chimeric Antigen ReceptorsIBA 10/2020 - 06/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 10/2020 - 11/2017
2	trans-sodium crocetinate (crocetin)IBA 02/2020 - 01/2019
2	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2019 - 01/2017
2	CytokinesIBA 11/2017 - 03/2005
1	Toll-Like Receptor 4IBA 10/2023
1	Interleukin-2 (IL2)IBA 08/2023
1	gastrofenzin (AN(5))IBA 01/2023
1	Dacarbazine (DIC)FDA LinkGeneric 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	lanreotide (Somatuline)FDA Link 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Chemokine ReceptorsIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2020
1	LigandsIBA 12/2020
1	Fluorouracil (Carac)FDA LinkGeneric 12/2020
1	Interferon-gamma (Interferon, gamma)IBA 10/2020
1	SurvivinIBA 10/2020
1	plerixafor FDA Link 10/2020
1	Cell Adhesion MoleculesIBA 10/2020
1	AntibodiesIBA 10/2020
1	pembrolizumabIBA 01/2020
1	Vorinostat FDA Link 01/2020
1	Amino Acids FDA Link 07/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	Monoclonal AntibodiesIBA 07/2018
1	Tyrosine Kinase InhibitorsIBA 07/2018
1	ErbB Receptors (EGF Receptor)IBA 07/2018
1	Chemotactic FactorsIBA 11/2017
1	Gemcitabine FDA Link 11/2017
1	ProteomeIBA 11/2017
1	Glutamine (L-Glutamine)FDA Link 11/2017
1	Apoptosis Regulatory ProteinsIBA 09/2017
1	ParaffinIBA 09/2017
1	AutoantigensIBA 09/2017
1	B7-H1 AntigenIBA 09/2017
1	Formaldehyde (Formol)FDA Link 09/2017
1	Biopolymers (Biopolymer)IBA 06/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	MucinsIBA 03/2015
1	Bile Pigments (Bilin)IBA 10/2014
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2014
1	B72.3 antibodyIBA 10/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014

Therapy/Procedure

16	Therapeutics 01/2024 - 01/2014
13	Immunotherapy 08/2023 - 09/2002
4	Drug Therapy (Chemotherapy) 05/2023 - 07/2009
1	Immunomodulation 10/2023
1	Radiotherapy 10/2023
1	Chemoradiotherapy 05/2023
1	Pancreatectomy 11/2022
1	Pancreaticoduodenectomy 01/2020
1	Hysterectomy 11/2016
1	Cholecystectomy 11/2016
1	Operative Surgical Procedures 11/2016
1	Neoadjuvant Therapy 01/2014